Xoma related patents. Most are Xoma patents, some are patents licensed to Xoma and a few merely reference Xoma. Posting since many at S.I. have no idea what Xoma does and accept the idea that Xoma has nothing to offer.
Searching 1996-2002...
Results of Search in 1996-2002 db for:
xoma: 117 patents.
Hits 1 through 50 out of 117
PAT. NO.
Title
1
6,423,825
Therapeutic derivative compounds derived from domain II of bactericidal/permeability-increasing protein
2
6,376,465
Therapeutic uses of BPI protein products in BPI-deficient humans
3
6,376,462
Lipopolysaccharide binding protein derivatives
4
6,376,217
Fusion proteins and polynucleotides encoding gelonin sequences
5
6,376,211
Agents and methods for inhibiting F1/F0 ATPase
6
6,355,616
Derivative compounds derived from or based on bactericidal/permeability-increasing protein
7
6,306,824
Uses of lipopolysaccharide binding protein
8
6,306,614
Measurement of analytes in whole blood
9
6,299,876
Cytotoxic drug therapy
10
6,290,953
Modulation of cellular proliferation with thymidine phosphorylase
11
6,277,821
Therapeutic uses of bactericidal/permeability-increasing protein dimer products
12
6,274,348
Methods for the preparation of positively charged proteins
13
6,274,344
Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
14
6,274,328
Method for quantifying LBP in body fluids
15
6,271,203
Anti-protozoan methods and materials
16
6,268,345
Bactericidal/permeability-increasing protein (BPI) compositions
17
6,255,284
Pharmaceutical composition
18
6,242,418
Therapeutic uses of BPI protein products for human meningococcemia
19
6,242,219
Methods for recombinant peptide production
20
6,228,834
Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
21
6,214,789
Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
22
6,204,023
Modular assembly of antibody genes, antibodies prepared thereby and use
23
6,203,997
Quantitation of analytes in whole blood
24
6,191,114
Immunological activity for a peptide of the limulus anti-LPS factor
25
6,191,112
Human therapeutic uses of BPI protein products
26
6,162,788
Uses of BPI protein products
27
6,159,683
Method of determining stage of sepsis
28
6,156,730
Anti-fungal peptides
29
6,153,730
Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
30
6,146,850
Proteins encoding gelonin sequences
31
6,146,631
Immunotoxins comprising ribosome-inactivating proteins
32
6,143,516
Identification of novel antimicrobial agents using membrane potential indicator dyes
33
6,140,306
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and
antibiotic
34
6,107,280
Antithrombotic materials and methods
35
6,093,573
Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
36
6,087,126
Bactericidal/permeability-increasing protein (BPI) deletion analogs
37
6,086,876
Methods and compositions for the inhibition of interleukin-12 production
38
6,066,620
Pharmaceutical compositions of bactericidal/permeability increasing protein (BPI)
39
6,063,764
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
40
6,057,293
Bactericidal/permeability-increasing protein (BPI) compositions
41
6,054,431
Anti-gram-positive bacterial methods and materials
42
6,051,553
Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
43
6,017,881
Method of treating conditions associated with intestinal ischemia/reperfusion
44
6,015,556
Cytotoxic drug therapy
45
6,013,631
Bactericidal/permeability-increasing protein (BPI) deletion analogs
46
6,013,629
Anti-protozoan methods and materials
47
5,990,086
Therapeutic uses of BPI protein products for human meningococcemia
48
5,990,082
Uses of lipopolysaccharide binding protein
49
5,973,116
Compounds for targeting
50
5,955,427
Pharmaceutical composition |
